Federal Supply Schedule 36F79719D0133
Award Date
5/1/19
Last Date to Order
1/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Vivus LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Viiv Healthcare Company, a foreign-owned for-profit manufacturer. The contract, valued at a ceiling of $1,870,730,000.00, is for the delivery of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from August 15, 2021, to August 14, 2026. This is a multiple-award contract, with no set-aside...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to the prime contractor Aprecia Pharmaceuticals Company. The contract has a ceiling value of $9,000,000.00 and a period of performance from March 1, 2017 through February 28, 2026. The purpose of this multiple award FSS contract is to provide pharmaceuticals, drugs, and hematology-related products under the General Services Administration (GSA) Schedule 65...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Upsher-Smith Laboratories, LLC, a for-profit limited liability company, is for the procurement of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) contract vehicle. The contract has a ceiling value of $194,946,890.00 and a period of performance from August 1, 2019 to January 31, 2026. The contract was awarded on a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Luye Pharma USA LTD, a foreign-owned for-profit organization. The $25,000 contract is for an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The period of performance runs from the award date of April 3, 2025 through September 30, 2025. No set-asides were used, and...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Saptalis Pharmaceuticals, LLC, a for-profit limited liability company. The contract is a multiple-award vehicle under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance ending on March 31, 2025 and a ceiling value of $25,000.00. The contract aims to procure a range of pharmaceutical and...